论文部分内容阅读
目的:观察米非司酮片联合戊酸雌二醇片治疗人工流产后宫腔残留的效果及其应用价值。方法:选取来东莞仁康医院就诊的人工流产术后确诊为宫腔残留的患者56例,随机分为:对照组28例,观察组28例,对照组患者口服米非司酮片,观察组患者口服米非司酮片和戊酸雌二醇片治疗;就治疗效果、患者满意程度及不良反应等情况,对两组患者进行分析比较。结果:观察组患者治疗有效率(89.29%)明显优于对照组(67.86%),观察组患者总满意率(96.43%)明显大于对照组(78.57%),两组数据差异有统计学意义(P<0.05);从不良反应发生率来看,观察组为14.29%,对照组为21.43%,,差异均无统计学意义(P>0.05)。结论:两种药物联合应用能够明显提高人工流产后宫腔残留的治疗效果,不良反应发生率不增加,患者满意度高,安全有效。
Objective: To observe the effect of mifepristone tablets and estradiol valerate tablets in the treatment of uterine cavity residue after induced abortion and its application value. Methods: Fifty-six patients with uterine cavity diagnosed after induced abortion were randomly divided into control group (n = 28), observation group (n = 28), control group (mifepristone group) and observation group Oral mifepristone tablets and estradiol valerate tablets treatment; the treatment effect, patient satisfaction and adverse reactions, the two groups of patients were analyzed and compared. Results: The total effective rate (89.29%) in observation group was significantly higher than that in control group (67.86%). The total satisfaction rate (96.43%) in observation group was significantly higher than that in control group (78.57%), P <0.05). From the incidence of adverse reactions, the observation group was 14.29%, while the control group was 21.43%, the difference was not statistically significant (P> 0.05). Conclusion: The combination of the two drugs can significantly improve the treatment of residual uterine cavity after abortion, the incidence of adverse reactions does not increase, patients with high satisfaction, safe and effective.